Wegovy can cost over $1,300 a month—but 340B quietly reshapes who pockets that money. We follow the dollars from patient to hospital, pharmacy, PBM, and Novo Nordisk.

Hospitals and clinics get big price breaks on brand-name drugs under the 340B program. Here’s how it works, who benefits, and who doesn’t.